Amneal Pharmaceuticals, Inc. AMRX Specialty — Product marketing
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketingAndAdvertisingExpense.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — product marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s specialty — product marketing?
- Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — product marketing of $7.82M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s specialty — product marketing changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s specialty — product marketing decreased by 2.4% year-over-year, from $8.01M to $7.82M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — product marketing?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — product marketing has grown at a 10.7% compound annual growth rate (CAGR), from $31.48M to $42.73M.
- What does specialty — product marketing mean?
- Reflects expenditures dedicated to advertising, brand promotion, and market awareness for specialty pharmaceutical products. It serves as a key indicator of the company's investment in driving demand and market share for its branded portfolio.